Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Sarah Heili"'
Autor:
Miguel Górgolas Hernández-Mora, Alfonso Cabello Úbeda, Laura Prieto-Pérez, Felipe Villar Álvarez, Beatriz Álvarez Álvarez, María Jesús Rodríguez Nieto, Irene Carrillo Acosta, Itziar Fernández Ormaechea, Aws Waleed Mohammed Al-Hayani, Pilar Carballosa, Silvia Calpena Martínez, Farah Ezzine, Marina Castellanos González, Alba Naya, Marta López De Las Heras, Marcel José Rodríguez Guzmán, Ana Cordero Guijarro, Antonio Broncano Lavado, Alicia Macías Valcayo, Marta Martín García, Javier Bécares Martínez, Ricardo Fernández Roblas, Miguel Ángel Piris Pinilla, José Fortes Alen, Olga Sánchez Pernaute, Fredeswinda Romero Bueno, Sarah Heili-Frades, Germán Peces-Barba Romero
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 303-309 (2021)
Introduction: Tocilizumab (TCZ) is an interleukin-6 receptor antagonist, which has been used for the treatment of severe SARS-CoV-2 pneumonia (SSP), which aims to ameliorate the cytokine release syndrome (CRS) induced acute respiratory distress syndr
Externí odkaz:
https://doaj.org/article/2aae212706174c78b0f4443668f39cdb
Autor:
Sarah Heili-Frades, Fernando Suarez-Sipmann, Arnoldo Santos, Maria Pilar Carballosa, Alba Naya-Prieto, Carlos Castilla-Reparaz, Maria Jesús Rodriguez-Nieto, Nicolás González-Mangado, German Peces -Barba
Publikováno v:
Critical Care, Vol 23, Iss 1, Pp 1-8 (2019)
Abstract Background Quantification of intrinsic PEEP (PEEPi) has important implications for patients subjected to invasive mechanical ventilation. A new non-invasive breath-by-breath method (etCO2D) for determination of PEEPi is evaluated. Methods In
Externí odkaz:
https://doaj.org/article/66dfd785d3ce4655a35094bface926b2
Autor:
Diego Velasco-Rodríguez, Juan-Manuel Alonso-Dominguez, Rosa Vidal Laso, Daniel Lainez-González, Aránzazu García-Raso, Sara Martín-Herrero, Antonio Herrero, Inés Martínez Alfonzo, Juana Serrano-López, Elena Jiménez-Barral, Sara Nistal, Manuel Pérez Márquez, Elham Askari, Jorge Castillo Álvarez, Antonio Núñez, Ángel Jiménez Rodríguez, Sarah Heili-Frades, César Pérez-Calvo, Miguel Górgolas, Raquel Barba, Pilar Llamas-Sillero
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247676 (2021)
We retrospectively evaluated 2879 hospitalized COVID-19 patients from four hospitals to evaluate the ability of demographic data, medical history, and on-admission laboratory parameters to predict in-hospital mortality. Association of previously publ
Externí odkaz:
https://doaj.org/article/c446bdcb696e418bb90f1a02d80fff41
Publikováno v:
Open Respiratory Archives, Vol 2, Iss 4, Pp 303-304 (2020)
Externí odkaz:
https://doaj.org/article/2ffb2636c749432eb54e6f667d37cf00
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archivos de bronconeumologia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a6f4d90173683fe055c61ea3c518e8
https://pubmed.ncbi.nlm.nih.gov/36153213
https://pubmed.ncbi.nlm.nih.gov/36153213
Autor:
José Manuel Carratalá Perales, Mirella Gaboli, Carlos Ferrando Ortola, Gemma Rialp Cervera, Juan Fernando Masa Jiménez, Manel Luján, Iñaki Gutiérrez Ibarluzea, Gonzalo Hernández, Javier García Fernández, César Cinesi Gómez, Julio Parrilla Parrilla, Mónica González, Miquel Ferrer Monreal, Julio Moreno Hernando, María Angeles Sánchez Quiroga, Oscar Peñuelas, Ana Sánchez Torres, Carlos Egea Santaolalla, Ana Concheiro Guisán, Arantxa Mas, Antonio Romero Berrocal, Rafael Uña, Alberto García-Salido, Sarah Heili-Frades, Joaquín Escámez, Eva Farrero Muñoz
Publikováno v:
Archivos de Bronconeumología. 57:415-427
Resumen El soporte respiratorio no invasivo (SRNI) comprende 2 modalidades de tratamiento, la ventilacion mecanica no invasiva (VMNI) y la terapia de alto flujo con canulas nasales (TAFCN) que se aplican en pacientes adultos, pediatricos y neonatales
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37bc93b0b1da41c6de629514a4e98de5
https://doi.org/10.1016/j.arbres.2020.08.013
https://doi.org/10.1016/j.arbres.2020.08.013
Autor:
Manel Luján, E. Farrero Muñoz, Arantxa Mas, G. Hernández, J. Parrilla Parrilla, Carlos Ferrando Ortola, Rafael Uña, A. Concheiro Guisán, Mónica González, Sarah Heili-Frades, I. Gutiérrez Ibarluzea, J.M. Carratalá Perales, A. Romero Berrocal, J. Moreno Hernando, M. Ferrer Monreal, Mirella Gaboli, J. García Fernández, Joaquín Escámez, C. Egea Santaolalla, Oscar Peñuelas, J.F. Masa Jiménez, Alberto García-Salido, G. Rialp Cervera, M.A. Sanchez Quiroga, César Cinesi Gómez, A.M. Sánchez Torres
Publikováno v:
Medicina Intensiva. 45:298-312
Resumen El soporte respiratorio no invasivo (SRNI) comprende 2 modalidades de tratamiento, la ventilacion meca-nica no invasiva (VMNI) y la terapia de alto flujo con canulas nasales (TAFCN) que se aplican en pacientes adultos, pediatricos y neonatale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae6e9c5bafa86ddc8f67b2a71f8c201
https://doi.org/10.1016/j.medin.2020.08.016
https://doi.org/10.1016/j.medin.2020.08.016
Autor:
María Jesús Rodríguez Nieto, Marta Lopez de las Heras, Silvia Calpena Martínez, Sarah Heili-Frades, Irene Carrillo Acosta, Aws Waleed Mohammed Al-Hayani, Laura Prieto-Pérez, Alba Naya, Javier Martinez, Miguel Ángel Piris Pinilla, Alicia Macias Valcayo, Marcel Jose Rodriguez Guzman, Ricardo Fernández Roblas, Miguel de Górgolas Hernández-Mora, Felipe Villar Álvarez, Alfonso Cabello Úbeda, José Fortes Alen, Pilar Carballosa, B. Alvarez, Fredeswinda Romero Bueno, Germán Peces-Barba Romero, Olga Sánchez Pernaute, Itziar Fernández Ormaechea, Marina Castellanos Gonzalez, Farah Ezzine, Antonio Broncano Lavado, Marta Martin Garcia, Ana Cordero Guijarro
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
Graphical abstract
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1eea5e71c1accdcc6c1f0a577af6c7
https://doi.org/10.1016/j.ijid.2020.10.045
https://doi.org/10.1016/j.ijid.2020.10.045
Autor:
Nikolas Bernaola, Guillermo de Lima, Miguel Riaño, Lucia Llanos, Sarah Heili-Frades, Olga Sanchez, Antonio Lara, Guillermo Plaza, Cesar Carballo, Paloma Gallego, Pedro Larrañaga, Concha Bielza
ObjectivesTo present a model that enhances the accuracy of clinicians when presented with a possibly critical Covid-19 patient.MethodsA retrospective study was performed with information of 5,745 SARS-CoV2 infected patients admitted to the Emergency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc7abb7b44ee6fe748d705157d1eef2
https://doi.org/10.1101/2022.05.09.22274832
https://doi.org/10.1101/2022.05.09.22274832
